DR. DAVID S BURGESS, PHARMD
Pharmacy at Queen Hts, San Antonio, TX
License number
Texas 36072
Category
Pharmacy
Type
Pharmacotherapy
Address
Address
8614 Queen Hts, San Antonio, TX 78254
Phone
(210) 567-8329
(210) 567-8328 (Fax)
(210) 567-8328 (Fax)
Personal information
See more information about DAVID S BURGESS at radaris.comName
Address
Phone
5130 Amesbury Dr APT 103, Dallas, TX 75206
502 N Mahan St, Clute, TX 77531
5544 County Road 437, Princeton, TX 75407
Professional information
David S Burgess, San Antonio TX - PHARMD
Specialties:
Pharmacotherapy
Address:
8614 Queen Hts, San Antonio 78254
(210) 567-8329 (Phone), (210) 567-8328 (Fax)
(210) 567-8329 (Phone), (210) 567-8328 (Fax)
Languages:
English
Enhanced Delivery Of Drug Compositions To Treat Life Threatening Infections
US Patent:
2007028, Dec 13, 2007
Filed:
Aug 26, 2005
Appl. No.:
11/660012
Inventors:
James Hitt - Midland MI, US
True Rogers - Midland MI, US
Brian Scherzer - Midland MI, US
Ian Gillespie - Linden MI, US
Paula Garcia - Midland MI, US
Nicholas Beck - Midland MI, US
Christopher Tucker - Midland MI, US
Timothy Young - Bay City MI, US
David Hayes - Midland MI, US
Robert Williams III - Austin TX, US
Keith Johnston - Austin TX, US
Jason McConville - Austin TX, US
Jay Peters - San Antonio TX, US
Robert Talbert - San Antonio TX, US
David Burgess - San Antonio TX, US
True Rogers - Midland MI, US
Brian Scherzer - Midland MI, US
Ian Gillespie - Linden MI, US
Paula Garcia - Midland MI, US
Nicholas Beck - Midland MI, US
Christopher Tucker - Midland MI, US
Timothy Young - Bay City MI, US
David Hayes - Midland MI, US
Robert Williams III - Austin TX, US
Keith Johnston - Austin TX, US
Jason McConville - Austin TX, US
Jay Peters - San Antonio TX, US
Robert Talbert - San Antonio TX, US
David Burgess - San Antonio TX, US
Assignee:
THE DOW CHEMICAL COMPANY - Midland MI
BOARD OF REGENTS UNIVERSITY OF TEXAS SYSTEM - Austin TX
BOARD OF REGENTS UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 31/7048, A61K 31/16, A61K 31/4164, A61K 31/4196, A61P 31/00, A61K 31/496, A61K 31/5375
US Classification:
514031000, 514231200, 514254070, 514256000, 514274000, 514383000, 514396000, 514399000, 514599000, 514789000
Abstract:
Inhalable compositions are described. The inhalable compositions comprise one or more respirable aggregates, the respirable aggregates comprising one or more poorly water soluble active agents, wherein at least one of the active agents reaches a maximum lung concentration (C) of at least about 0.25 μg/gram of lung tissue and remains at such concentration for a period of at least one hour after being delivered to the lung. Methods for making such compositions and methods for using such compositions are also disclosed.